Free Trial

AltaCorp Capital's Rating of Willow Biosciences on 3/26/2020

On March 26, 2020, AltaCorp Capital updated its outlook on Willow Biosciences (TSE:WLLW) with the action "Lower Price Target", setting a price target of C$2.75. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from AltaCorp Capital

DateCompanyAction
7/30/2020
Tervita Co. stock logo
TEV
Tervita
Upgrade
7/28/2020
Stuart Olson Inc. stock logo
SOX
Stuart Olson
Downgrade
7/21/2020
Organigram Holdings Inc. stock logo
OGI
Organigram
Downgrade
7/21/2020
Organigram Global Inc. stock logo
OGI
Organigram Global
Downgrade
7/20/2020
Halliburton Company stock logo
HAL
Halliburton
Upgrade
7/6/2020
Pinnacle Renewable Energy Inc. stock logo
PL
Pinnacle Renewable Energy
Reiterated Rating
More Ratings From AltaCorp Capital